Gainesville, FL – October 7, 2019 – Evren Technologies Inc. will compete with 15 other emerging companies in the Early Stage Mentoring closed sessions at the 2019 Southeast BIO (SEBIO) Investor & Partnering Forum.
A committee of investment professionals selected Evren Technologies to present for a team of mentors at the closed-door sessions on the afternoon of Wednesday, November 6. The mentors are a mix of investment, business development, and technology transfer professionals, entrepreneurs, and legal and financial service providers.
“We are all very excited for the opportunity to participate in this year’s SEBIO conference. Given the quality of past participants, we believe Evren is a perfect fit for this conference. We hope to maintain that standard of excellence.” - Blythe Karow, President and COO of Evren Technologies.
Evren will compete for one of the four spots in the Early Stage Shootout round the following Thursday, November 7. Shootout round presentations will be open to the entire conference. A panel of judges will select an overall winner.
In addition to the Early Stage Mentoring/Shootout, the SEBIO Investor & Partnering Forum features world-class speakers and panels with engaging conversations by industry leaders. The conference is being hosted in Miami on November 6-7, 2019.
About Evren Technologies
Evren Technologies, founded in 2018, is a privately-held medical device company headquartered in Newberry, Florida, near the University of Florida. Evren’s mission is to advance the treatment of PTSD and other psychological disorders through wearable neuromodulation products. The Company’s initial product, the Phoenix™, provides transcutaneous vagal nerve stimulation (tVNS) to treat PTSD in an effective, discreet earbud design.
About SEBIO Investor & Partnering Forum
The conference provides an unparalleled opportunity to meet key decision makers in the regional and national life science and medical technology communities. Now in its 21st year, the SEBIO Investor & Partnering Forum has built a loyal following, attracting thought leaders and investors from across the country.
More than 300 biotech and medtech investors, corporate executives, university representatives, and entrepreneurs will attend the event this year. This is a rich opportunity to showcase your company at the most significant annual life science conference in the Southeast.
To date, more than 220 later stage and 180 early stage companies that participated in previous SEBIO Investor & Partnering Forums have raised more than $2.5 billion in public and private funding. These numbers speak to the quality of our presenting companies.
M. Blythe Karow
Evren Technologies, Inc.
President & COO